lexiara

doc__heading__para__13

Institutions can be granted the approval to apply the favourable treatment set forth in Article 133(5) of the CRR not only on equity exposures incurred under legislative programmes developed and financed by the EU or the Member State in which they are authorised, but also for those developed and financed by other Member States.

· All articles ·

Source: EUR-Lex (Cellar) · retrieved 2026-09-07 · Text as adopted (Official Journal); later amendments are not incorporated in this text.